Metraipolis › archive › dc_730dd3c6355f

ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer — Europe PMC PMID:41628058

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41628058
DOI
10.1158/2767-9764.crc-25-0119
License (as archived)
solo-consultazione
Archived
2026-11-06T09:12:05.400Z
SHA-256 of the archived text
5b3a98753787ef920d8214653ac2832a2c1c36202b52fced9a07aebad8055efa
Stable URL of this page
https://metraipolis.com/documento/dc_730dd3c6355f

How to cite

ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer — Europe PMC PMID:41628058 — Europe PMC (en), https://europepmc.org/article/MED/41628058 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_730dd3c6355f (Metraipolis archive dc_730dd3c6355f, sha256 5b3a98753787ef920d8214653ac2832a2c1c36202b52fced9a07aebad8055efa)
BibTeX
@misc{dc730dd3c6355f,
  title = {ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer — Europe PMC PMID:41628058},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41628058},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_730dd3c6355f; sha256 5b3a98753787ef920d8214653ac2832a2c1c36202b52fced9a07aebad8055efa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41628058. Agents can read the archived copy with the MCP tool read_document.